 ImmunoGen, Inc. NASDAQ:IMGN Q3 2022 Earnings Conference Call November 4, 2022 8:00 AM ET Company Participants Anabel Chan - Head, Investor Relations Mark Enyedy - President, CEO Director Anna Berkenblit - SVP Chief Medical Officer Susan Altschuller - SVP CFO Conference Call Participants John Newman - Canaccord Genuity Michael Schmidt - Guggenheim Securities Etzer Darout - BMO Capital Markets Faisal Khurshid - SVB Securities Andy Hsieh - William Blair Company Peter Lawson - Barclays Bank Arthur He - H.C. Wainwright Co. Boris Peaker - Cowen and Company Kelly Shi - Jefferies Daniel Wolle - JPMorgan Chase Co. Operator Good morning, and welcome to ImmunoGens Third Quarter 2022 Financial and Operating Results Conference Call. 